| ITCTX | RLBCX | ITCTX / RLBCX | |
| Total Expense Ratio | 1.05 | 0.89 | 118% |
| Annual Report Gross Expense Ratio | 1.05 | 0.89 | 118% |
| Fund Existence | 23 years | 23 years | - |
| Gain YTD | -4.884 | 13.390 | -36% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.93B | 263B | 3% |
| Annual Yield % from dividends | 2.66 | 1.46 | 182% |
| Returns for 1 year | -5.88 | 7.95 | -74% |
| Returns for 3 years | 10.64 | 38.18 | 28% |
| Returns for 5 years | -6.74 | 36.53 | -18% |
| Returns for 10 years | 14.29 | 67.23 | 21% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ESPAX | 36.17 | 1.13 | +3.22% |
| Allspring Special Small Cap Value A | |||
| LMCQX | 33.00 | 0.61 | +1.88% |
| Lord Abbett Mid Cap Stock R2 | |||
| RMDCX | 3.28 | 0.04 | +1.23% |
| Virtus Silvant Mid-Cap Growth C | |||
| RRBGX | 189.49 | 0.69 | +0.37% |
| T. Rowe Price Blue Chip Growth R | |||
| MCYAX | 13.08 | -0.17 | -1.28% |
| NYLI Candriam Emerging Markets Eq Cl A | |||